To describe Stenotrophomonas maltophilia infection in children, we reviewed
the medical records of patients with isolates from nonrespiratory sites an
d identified 85 episodes, 51 (60%) of which represented true infection. For
ty-two episodes (82.4%) were hospital acquired. Commonly associated with S.
maltophilia infection were underlying illness (in 90.2% of cases), previou
s hospitalizations (in 78.7%), previous antibiotic exposure (in 78.4%), and
the presence of a central venous catheter (in 76.5%). Polymicrobial isolat
es were obtained in 70.6% of episodes; Pseudomonas aeruginosa and Acinetoba
cter species were the most common coisolates. Bloodstream infection was the
most frequent clinical syndrome (32 [63%] of 51 episodes). Fever or sepsis
occurred in 22 (69%) and shock in 10 (31%) of 32 episodes. Infection at ot
her sites was less severe. The most active antibiotics in vitro were trimet
hoprim-sulfamethoxazole and ticarcillin-clavulanate. The overall and attrib
utable mortality rates were 12.5% and 6.3%, respectively. S. maltophilia ap
pears to be an important cause of nosocomially acquired bacteremia in child
ren. The significance in children of isolation from other sites is less cle
ar.